RNA interference by modified short interfering nucleic acid

Details for Australian Patent Application No. 2010212416 (hide)

Owner Sirna Therapeutics, Inc.

Inventors Morrissey, David; Macejak, Dennis; McSwiggen, James; Fosnaugh, Kathy; Beigelman, Leonid; Pavco, Pamela; Haeberli, Peter; Jamison, Sharon; Zinnen, Shawn; Mokler, Victor

Agent Spruson & Ferguson

Pub. Number AU-B-2010212416

Parent 2006203725

Filing date 18 August 2010

Wipo publication date 9 September 2010

Acceptance publication date 20 October 2011

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 31/7115 (2006.01) - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine

A61K 31/712 (2006.01) - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

A61K 31/7125 (2006.01) - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 21/00 Drugs for disorders of the muscular or neuromuscular system

Event Publications

2 September 2010 Complete Application Filed

9 September 2010 Application Open to Public Inspection

  Published as AU-B-2010212416

20 October 2011 Application Accepted

  Published as AU-B-2010212416

16 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212417-Immunogenic composition

2010212415-Self-adjustment of a hearing aid